Prevention of Diabetic Foot Ulcers at Primary Care
Prevention of Diabetic Foot Ulcers at Primary Care
Prevention of Diabetic Foot Ulcers at Primary Care
DERMATOLOGY
Open Journal PUBLISHERS
Review
Prevention of Diabetic Foot Ulcers at Primary Care Level
Josephine Priyadarshini, RN; Seham Abdi, RN; Azza Metwaly, RN; Badria Al-Lenjawi, MD; Janelle San Jose, RN;
Hashim Mohamed, MD*
Corresponding author
*
Hashim Mohamed, MD
Associate Professor, Weill Cornell Medicine-Qatar, Doha, Qatar; E-mail: [email protected]
Article information
Received: January 9th, 2018; Revised: January 30th, 2018; Accepted: February 6th, 2018; Published: February 6th, 2018
ABSTRACT
Diabetic foot ulcer (DFT) prevention is best achieved at primary care level and should begin with education, appropriate pro-
tective footwear, glycaemic control and regular screening for loss of protective sensation. In the west, specialized diabetic or
podiatry clinics may assess and quantify neuropathy with many tools including monofilaments, biothesiometry, corneal confocal
microscopy and nerve conduction studies. Vascular assessment can be done via measuring ankle-brachial index, duplex ultrasound
studies and toe pressure. Other foot assessment may include measuring plantar foot pressure using computerized dynamic foot
studies (computerized insole sensor system). The ability to stratify patients based on risks is carried out on the basis of a thorough
medical and surgical history in conjunction with these measurements thereby allowing clinicians to determine the type of inter-
vention. Effective strategies for foot ulceration prevention include educating patients, their families, and healthcare workers about
adequate foot care and regular foot examinations along with optimal glycaemic control and smoking cessation. Other effective
clinical interventions may include, foot hygiene, debridement of calluses, management of foot deformities which may at times
require prophylactic foot surgery. Counseling patients regarding daily proper footwear and hygiene should be stressed during each
clinic visit. Educating, screening and managing patients with diabetic foot ulceration and or complications is an essential primary
healthcare strategy to prevent unnecessary morbidity and mortality related to diabetic foot. An integrated (interdisciplinary) ap-
proach including, family physicians with special interest in the diabetic foot, diabetic educators, nurses and family members is a
vital component in this regard.
Keywords
Diabetic foot ulcer (DFU); Neuropathy; Glycaemic control.
allows to copy, redistribute, remix, transform, and reproduce in any medium or format, even commercially, provided the original work is properly cited.
Review | Volume 3 | Number 1| 4
PUBLISHERS
Dermatol Open J. 2018; 3(1): 4-9. doi: 10.17140/DRMTOJ-3-129
Specific Foot Care Advice Given to Patients with High-Risk Feet How Can I Take Care of my Feet?
in Order to Prevent DFU
1. Wash your feet daily using warm water (test it by your elbow),
• Wash your feet daily with mild soaps and keep it moisturized. a mild soap and dry using a towel especially the areas between
• Avoid walking barefoot indoors. your toes.
• Inspect your feet daily. 2. Do not soak your feet because this will dry out the skin and
do not use whirlpool – water if you suffer from cold feet but
• Contact your doctor or podiatrist if there is redness or swelling rather wear socks made of cotton and wool to keep your feet
or a minor cut. warm.
• Wear well-fitting shoes which should offer enough room to
move your toes freely. 3. Use a moisturizer (10% urea cream) because dry skin cracks
and if this happens it can lead to infection and ulcer forma-
• If needed wear special shoes if you have been supplied with tion.
them.
4. Dry up between your toes after washing your feet.
• Never self-treat your own corn or callus. Consult a doctor in-
stead. 5. Cutting your nails regularly once a week is usually enough
• Avoid using a hot water bottle. but if your nails are thick; don’t attempt to cut them because
you may injure yourself. Your doctor can help you by using a
• Wear woolen socks in bed if needed. special scissor. Nails should be cut across and not in a semi-
circular fashion and use a nail clipper instead of scissor & do
General Advice Necessary to Help you Protect your Feet not cut nails too close to the skin.
(Figure 1)
FOOTWEAR CARE
Foot Examination
1. Never walk barefoot even inside the house, socks should be
1. Check your feet daily because some people may not feel injury worn (cotton) all the time to keep skin moist and shoes must
if the nerves in their feet are not working properly. also be worn, to avoid injury to your feet.
2. So, you should look for: 2. Check your shoes before you wear them because you may find
foreign bodies such pieces of stones inside.
5. Avoid high heels shoes which may put extra pressure on the Things you need to take care of:
bottom of your feet.
1. Keep your blood sugar under control since this will help in
6. If you want to exercise you need to wear soft tennis shoes and preventing complications and speeds up healing. This can be
check your feet before and after exercise. an achieved by eating a healthy and balanced diet, exercise and
proper medical follow-up.
7. Sandals should not be worn nor should you wear nylon socks.
2. Avoid smoking.
Consult your doctor: Consult your doctor before buying a new
pair of shoes and if you do, you need to wear it 1 hour daily initially 3. Have a regular follow-up with your doctor regarding foot care.
until it softens up slowly over several days
4. Report any change in your skin no matter how trivial it may
1. Let your healthcare provider check your feet on a yearly basis look.
at least, but if you are suffering from one of the following you
need to be checked more often: PREVENTION AND TREATMENT OF PERIPHERAL
VASCULAR DISEASE
A. Suffering from numbness or pins and needles in your feet.
The lack of blood supply or ischemia is one of the major reasons
B. Burning sensation in your feet. for diabetic foot ulcers and thereafter amputations. Atherosclerotic
C. Pain in your feet or back of your leg. lesions are more diffuse and distal in diabetics.10 The risk of vascu-
lar diseases in diabetics can be reduced, by lifestyle modifications
D. Cold sensation in your feet.
including daily exercise and avoiding smoking. Many drugs are out
in the market promoted as being useful in the prevention of DFU
2. If you have abnormal looking toes.
and peripheral vascular disease; however, adequate controlled trials
supporting these claims are lacking. Despite this, an argument for
Skin care: To help you have moist skin you need to
the use of aspirin, clopidogrel, statins, fibrates, ACE inhibitors and
folic acid in diabetics can be made in the light of these pieces of
1. Use a moisturizer such as 10% urea cream or Lanolin.
evidence.11-14 On the other hand, agents such as naftidrofuryl and
cilostazol, although helpful in controlling symptoms of intermit-
2. Avoid barrier creams and ointments such as Vaseline because
tent claudication, have not found widespread use in diabetics with
it will not moisturize your feet.
peripheral vascular disease as there is paucity of data on preven-
tion of DFU or amputation.15,16 If a leg is fully ischaemic, vascular
3. Avoid applying a moisturizer in between your toes.
surgery could improve the blood supply.17
4. Avoid Henna because it will dry your skin & cause the skin to
GLYCAEMIC CONTROL
crack.
Normal glucose level is the first line of defense against chronic
If you see any of the following changes in the nail please consult
complications of diabetes. Optimal glycaemic control may prevent
your doctor (Figure 2).
the development of neuropathy. Intensive blood glucose control
reduced the development of neuropathy by 40% in patients with
Figure 2. General Changes Observed in the Nails of Diabetic Foot Patient
type II diabetes18 and by about 60% in patients with type 1 diabe-
tes.19 Raised HbA1c has also been associated with DFU, amputa-
tions and peripheral vascular disease. Therefore, it is very impor-
tant to optimize glycaemic control to prevent DFU in the long run.
REGULAR PODIATRY
Similarly, if you see the following changes in your skin please con-
Podiatry services are essential in the prevention and treatment of
sult your doctor (Figure 3).
DFU.20 Patients should avoid self-treating corns and calluses and
There has not been any study to specifically look into various life- 2. Goweda R, Shatla M, Alzaidi A, et al. Assessment of Knowledge
styles and the development of DFU. In view of available knowl- and practices of diabetic patients regarding diabetic foot care, in
edge based on the general population, the following changes can Makkah, Saudi Arabia. Journal of Family Medicine and Health Care.
be advocated. 2017; 3(1): 17-22. doi: 10.11648/j.jfmhc.20170301.14
limb loss. In: Barbul A, Caldwell MD, et al., eds. Clinical and Experi- 479-487.
mental Approaches to Dermal and Epidermal Repair: Normal and Chronic
Wounds. New York, USA: Wiley-Liss; 1991: 27-43. 17. Yazdanpanah L, Nasiri M, Adarvishi S. Literature review on
the management of diabetic foot ulcer. World J Diabetes. 2015; 6(1):
5. Alexiadou K, Doupis J. Management of diabetic foot ulcers. Di- 37-53. doi: 10.4239/wjd.v6.i1.37
abetes Therapy. 2012; 3(1): 4. doi: 10.1007/s13300-012-0004-9
18. UK Prospective diabetes study (UKPDS) group. Intensive
6. Wu SC, Driver VR, Wrobel JS, Armstrong DG. Foot ulcers in blood-glucose control with sulphonylureas or insulin compared
the diabetic patient, prevention and treatment. Vasc Health Risk with conventional treatment and risk of complications in Rathur
Manag. 2007; 3(1): 65-76. & Rajbhandari 61patients with type 2 diabetes (UKPDS 33). Lancet
1998; 352: 837-853. doi: 10.1016/S0140-6736(98)07019-6
7. Yazdanpanah L, Nasiri M, Adarvishi S. Literature review on the
management of diabetic foot ulcer. World J Diabetes. 6(1): 37-53. 19. The Diabetes Control and Complication Trial Research Group
doi: 10.4239/wjd.v6.i1.37 (DCCT). The diabetes control and complications research group.
The effect of intensive treatment of diabetes on the development
8. Ferreira RC, Gonçalez DH, Fonseca Filho JM, Costa MT, San- and progression of long-term complication in insulin-dependent
tin RAL. Mid-foot charcot arthropathy in diabetic patients: com- diabetes mellitus. N Eng J Med. 1993; 329: 977-986.
plication of an epidemic disease. Revista Brasileira de Ortopedia.
2012; 47(5): 616-625. doi: 10.1590/S0102-36162012000500013 20. Barshes NR, Sigireddi M, Wrobel JS, et al. The system of care
for the diabetic foot: objectives, outcomes, and opportunities. Dia-
9. Yazdanpanah L, Nasiri M, Adarvishi S. Literature review on the bet Foot Ankle. 2013; 4. doi: 10.3402/dfa.v4i0.21847
management of diabetic foot ulcer. World J Diabetes. 2015; 6(1): 37-
53. doi: 10.4239/wjd.v6.i1.37 21. Amemiya A, Noguchi H, Oe M, et al. Comparison of gait
features between feet with callus or corns and normal feet us-
10. He C, Yang J, Li Y, et al. Comparison of lower extremity ath- ing motion sensors in people with diabetes and people with-
erosclerosis in diabetic and non-diabetic patients using multidetec- out diabetes. J Diabetes Sci Technol. 2016; 10(2): 614-615. doi:
tor computed tomography. BMC Cardiovascular Disorders. 2014; 14: 10.1177/1932296815616135
125. doi: 10.1186/1471-2261-14-125
22. Bus SA, Waaijman R, Arts M, et al. Effect of custom-made
11. Jung JH, Tantry US, Gurbel PA, Jeong YH. Current antiplatelet footwear on foot ulcer recurrence in diabetes: A multicenter ran-
treatment strategy in patients with diabetes mellitus. Diabetes Metab domized controlled trial. Diabetes Care. 2013; 36(12): 4109-4116.
J. 2015; 39(2): 95-113. doi: 10.4093/dmj.2015.39.2.95 doi: 10.2337/dc13-0996
12. PL Detail-Document. Does my patient with diabetes need an 23. Waaijman R, Keukenkamp R, de Haart M, et al. Adherence to
aspirin, statin, ACE inhibitor, or ARB? Pharmacist's Letter 2012; wearing prescription custom-made footwear in patients with dia-
28(11): 281101. betes at high risk for plantar foot ulceration. Diabetes Care. 2013;
36(6): 1613-1618. doi: 10.2337/dc12-1330
13. Yusuf S, Sleight P, Pogue J, et al; The Heart Outcomes Pre-
vention Evaluation Study Investigators. Effects of an angiotensin-
24. Wu SC, Driver VR, Wrobel JS, Armstrong DG. Foot ulcers in
converting-enzyme inhibitor, ramipril, on cardiovascular events in
the diabetic patient, prevention and treatment. Vascular Health and
high-risk patients. N Engl J Med. 2000; 342: 145-153. doi: 10.1056/
Risk Management. 2007; 3(1): 65-76.
NEJM200001203420301
14. Robins SJ, Rubins HB, Faas FH, et al. Insulin resistance and 25. Yazdanpanah L, Nasiri M, Adarvishi S. Literature review on
cardiovascular events with low HDL cholesterol: The Veterans Af- the management of diabetic foot ulcer. World J Diabetes. 2015; 6(1):
fairs HDL Intervention Trial (VA-HIT). Diabetes Care. 2003; 26: 37-53. doi: 10.4239/wjd.v6.i1.37
1513-1517. doi: 10.2337/diacare.26.5.1513
26. Eilat-Adar S, Sinai T, Yosefy C, Henkin Y. Nutritional recom-
15. Squires H, Simpson E, Meng Y, et al. A systematic review and mendations for cardiovascular disease prevention. Nutrients, 2013;
economic evaluation of cilostazol, naftidrofuryl oxalate, pentoxi- 5(9): 3646-3683. doi: 10.3390/nu5093646
fylline and inositol nicotinate for the treatment of intermittent
claudication in people with peripheral arterial disease. Health Tech- 27. Turan Y, Ertugrul BM, Lipsky BA, Bayraktar K. Does physi-
nol Assess. 2011; 15(40): 1-210. doi: 10.3310/hta15400 cal therapy and rehabilitation improve outcomes for diabetic foot
ulcers? World J Exp Med. 2015; 5(2): 130-139. doi: 10.5493/wjem.
16. Rendell M, Cariski AT, Hittel N, Zhang P. Cilostazol treatment v5.i2.130
of claudication in diabetic patients. Curr Med Res Opin. 2002; 18:
28. Kastenbauer T, Sauseng S, Sokol G, Auinger M, Irsigler K. A men. J Am Coll Nutr. 2014; 22: 185-194.
prospective study of predictors for foot ulceration in type 2 diabe-
tes. J Am Podiatry Med Assoc. 2001; 91: 343-350. 30. Mohamed H. Evidence Based Counseling for Health Care Profession-
als. Saarbrücken, Germany: LAP LAMBERT Academic Publish-
29. Meyer KA, Conigrave KM, Chu NF, et al. Alcohol consump- ing; 2017.
tion patterns and HbA1c, C-peptide and insulin concentrations in